Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AddLife M&A Activity 2017

Feb 22, 2017

2877_iss_2017-02-22_914a5c88-51e5-4fb7-8996-b0e9444d95dc.pdf

M&A Activity

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

AddLife acquires Norwegian Hepro Group – leader in home care products and welfare technology

AddLife signed an agreement today for the acquisition of all shares in the three companiesof the Hepro Group: Hepro AS, Mektron AS and Hepro Sverige AB. The Hepro Group develops, designs and markets assistive technology within home care and welfare technology. These products facilitate health care and social services in the home, a market undergoing strong growth. The acquisitionswill be a positive addition to the other companies in AddLife'sMedtech business area.

-"With a growing and aging population throughout the Nordic region, there is a strong need for assistive equipment for home care, and it is only expected to growstronger. The acquisition involves functional products and digital welfare technology that will provide greater independence, activity and security for people with disabilities", says Kristina Willgård, CEO, AddLife.

The Hepro Group is successfully positioned in the Norwegian market as one of the leading companies in home care and welfare technology. The companies' products and solutions are currently sold primarily to public sector and private healthcare players, with some sales directly to the end consumer. The companies have 40 employees and sales of NOK 155 million, mainly in the Norwegian market.

The acquisitions represent a strategic entry for AddLife in the field of home care in Norway, while laying the foundation for continued expansion in an attractive growth area. The acquisitions are also an excellent addition to Svan CareAB, a company acquired in October 2016. The Hepro Group markets parts of Svan CareAB's line of products on the Norwegian market, while Svan CareAB markets parts of the Hepro Group's line of products on the Swedish market.

Ownership will come effective on 1 March 2017. The acquisition is expected to have a marginally positive effect onAddLife's earnings per share during the current financial year.

Stockholm, 22 February 2017

AddLifeAB (publ.) For more information, please contact Kristina Willgård, CEO, AddLifeAB, +46 705 10 12 23 Lars-Erik Rydell, business area manager of Medtech, AddLifeAB, +46 709 46 48 77

AddLife is an independent player in the Life Science sector, offering high-quality products, services and advice to the private and public sectors, above all in the Nordic region. AddLife has about 550 employees in some 30 subsidiaries that operate under their own brands. The Group has annual sales of about SEK 1.9 billion. The AddLife share is listed on Nasdaq Stockholm.

This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10:30 a.m. CET on 22 February 2017.